News
$XBIO - Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center E
Oct 15, 2026 · ThinkSabio Blog
$XBIO - Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center Evaluating Systemic DNase in Combination with CAR T Cells for Large B-Cell Lymphoma
15-OCT-2026 08:46 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
